Michelle Mitchell, Chief Executive at Cancer Research UK, shared on LinkedIn:
“Progress against cancer relies on outstanding researchers and it’s thanks to generous investments like the one made by the ALBORADA Trust that means more talented scientists have the opportunity to become leaders in cancer research.
We launched the More Research, Less Cancer philanthropic campaign in February 2024 with the aim to raise £400m to help accelerate a new golden age of cancer research and this new £9m donation will support researchers to establish independent careers at a critical stage in their development, and bring bold new ideas, expertise and discoveries into the field.
Supporting the next generation of research leaders is essential to driving future breakthroughs and ensure the UK remains at the forefront of cancer research and innovation.
I’m grateful to everyone who has supported the More Research, Less Cancer campaign to date. Your commitment means more research. And more research means less cancer.”
The ALBORADA Trust was founded by Kirsten Rausing in 2001 and celebrates its 25th anniversary this year. The Trust’s funding was initially based on the racecourse earnings of the Founder’s homebred World Champion filly ALBORADA. It supports medical and veterinary research and education, the welfare of animals and the provision of relief to disaster areas worldwide.
‘The ALBORADA Trust has supported important work in cancer research for many years, and we are delighted to strengthen that commitment through a new long-term partnership with Cancer Research UK,’ Founding Trustee of The ALBORADA Trust, Kirsten Rausing CBE DL said.
The Trust has supported our work since 2005. Previous funding has included support for research infrastructure at our Cambridge Institute and an MB-PhD studentship through the Borysiewicz Clinical PhD Fund, which helps develop the next generation of clinician scientists.
In addition to its £9m gift to us, the ALBORADA Trust has committed £1m to Addenbrooke’s Charitable Trust (ACT) in support of their new Cambridge Cancer Research Hospital, bringing its total investment in cancer research and care to £10m.
Since its inception, the Trust has distributed over £60m. This long-term award towards cancer research in the UK will take its total funding to c. £70m.
by Krishna Sharma, Philanthropy and partnerships
You can also read: Cure Cancer Research Grants 2027 for Early-Career Researchers
